CrowdStrike Form 144 Discloses 6,250‑Share Sale via Goldman Sachs

Rhea-AI Filing Summary

CrowdStrike Holdings, Inc. (CRWD) Form 144 notifies the SEC of a proposed sale of 6,250 common shares via Goldman Sachs & Co. LLC with an approximate aggregate market value of $2,577,875 and an approximate sale date of 09/04/2025 on the NASD. The filing states these shares were originally acquired on 08/21/2013 from Accel Growth Fund II Associates LLC and that payment for those shares was made on 06/03/2020 in securities. The filer reports two prior common‑share sales in the past three months by Potomac Investments, LP: 6,250 shares sold on 07/03/2025 for $3,202,657.50 and 6,250 shares sold on 08/01/2025 for $2,794,288.75. The filer attests no undisclosed material adverse information.

Positive

• Transparent disclosure of proposed sale details including broker, share count, market value, and acquisition history
• Past sales and proceeds are reported for the prior three months, improving investor visibility into recent disposition activity

Negative

• Clustered insider/affiliate sell activity with three sales of 6,250 shares in a short period could increase selling pressure
• Form 144 shows cashing out of previously held stake by an affiliate, which some investors may interpret negatively

Insights

Securities Analyst

TL;DR: Insider/affiliate sales totaling 6,250 shares planned; two recent 6,250‑share disposals in prior months could be dilutive signals to watch.

The Form 144 shows a planned sale of 6,250 common shares through Goldman Sachs on 09/04/2025, adding to two recent sales of the same size on 07/03/2025 and 08/01/2025 by Potomac Investments, LP, with combined gross proceeds of roughly $8.79 million. While the absolute size is small relative to the reported outstanding shares (250,955,140), clustered disposals over a short period can influence short‑term supply dynamics in the stock. The filing provides acquisition provenance (Accel Growth Fund II) which documents secondary market transfers rather than primary dilution.

Corporate Governance Expert

TL;DR: Filing is routine Form 144 disclosure for planned affiliate sale; signer confirms no material undisclosed information.

The notice includes the standard attestation that the seller is not aware of any undisclosed material adverse information and references potential reliance on Rule 10b5‑1 if applicable. The record of past sales and the declared acquisition date provide transparency about beneficial ownership history. No governance actions, officer resignations, or related‑party transactions are disclosed in this document.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	6250	2577875	250955140	09/04/2025	NASD

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/21/2013	Acquired from a distribution by a partnership or investment vehicle	Accel Growth Fund II Associates LLC			6250	06/03/2020	Securities

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Potomac Investments, LP 206 East 9th Street Suite 1400 Austin TX 78701	Common	07/03/2025	6250	3202657.5
Potomac Investments, LP 206 East 9th Street Suite 1400 Austin TX 78701	Common	08/01/2025	6250	2794288.75

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for CRWD disclose about the planned sale?

The filing discloses a proposed sale of 6,250 common shares via Goldman Sachs & Co. LLC with an aggregate market value of $2,577,875 and an approximate sale date of 09/04/2025.

Who originally acquired the shares and when?

The shares were acquired on 08/21/2013 from Accel Growth Fund II Associates LLC.

Were there other recent sales reported in the filing?

Yes. Potomac Investments, LP reported selling 6,250 shares on 07/03/2025 for $3,202,657.50 and 6,250 shares on 08/01/2025 for $2,794,288.75.

How many shares of CRWD are outstanding per the filing?

The filing lists 250,955,140 shares outstanding.

Does the filer certify they have material nonpublic information?

By signing, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.